Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 3
2003 3
2004 4
2005 4
2006 4
2008 2
2009 2
2010 3
2011 3
2012 9
2013 8
2014 7
2015 5
2016 8
2017 8
2018 11
2019 12
2020 10
2021 13
2022 6
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 37352008

101 results

Results by year

Filters applied: . Clear all
Page 1
The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiation.
Kadena S, Urabe F, Iwatani K, Suzuki H, Imai Y, Tashiro K, Tsuzuki S, Honda M, Koike Y, Shimomura T, Aoki M, Sato S, Takahashi H, Miki K, Kimura T. Kadena S, et al. Int J Clin Oncol. 2023 Aug;28(8):1092-1100. doi: 10.1007/s10147-023-02359-1. Epub 2023 May 25. Int J Clin Oncol. 2023. PMID: 37227547
Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer.
Galalae RM, Martinez A, Mate T, Mitchell C, Edmundson G, Nuernberg N, Eulau S, Gustafson G, Gribble M, Kovács G. Galalae RM, et al. Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1048-55. doi: 10.1016/j.ijrobp.2003.08.003. Int J Radiat Oncol Biol Phys. 2004. PMID: 15001244 Clinical Trial.
Overall survival comparison between androgen deprivation therapy (ADT) plus external beam radiation therapy (EBRT) vs ADT plus EBRT with brachytherapy boost in clinically node-positive prostate cancer.
Fischer-Valuck BW, Rao YJ, Brenneman RJ, Patel PR, Filson CP, Jani AB, Liu Y, Goyal S, Xu K, Weiss A, Kucuk O, Cimmino C, Szabo S, Rossi P, Baumann BC, Pattaras J, Hershatter B, Patel SA. Fischer-Valuck BW, et al. Brachytherapy. 2020 Sep-Oct;19(5):557-566. doi: 10.1016/j.brachy.2020.05.007. Epub 2020 Jul 3. Brachytherapy. 2020. PMID: 32624405
Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
Ecke TH, Huang-Tiel HJ, Golka K, Selinski S, Geis BC, Koswig S, Bathe K, Hallmann S, Gerullis H. Ecke TH, et al. Int J Mol Sci. 2016 Nov 10;17(11):1879. doi: 10.3390/ijms17111879. Int J Mol Sci. 2016. PMID: 27834929 Free PMC article.
The effectiveness of high-dose-rate brachytherapy with external beam radiotherapy for clinically locally advanced and node-positive prostate cancer: long-term results of a retrospective study.
Makino T, Sakurai T, Takamatsu S, Iwamoto H, Yaegashi H, Iijima M, Kawaguchi S, Nohara T, Shigehara K, Izumi K, Kadono Y, Mizokami A. Makino T, et al. Int J Clin Oncol. 2021 Dec;26(12):2310-2317. doi: 10.1007/s10147-021-02023-6. Epub 2021 Sep 7. Int J Clin Oncol. 2021. PMID: 34494172
The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition.
Pellizzon AC, Salvajoli J, Novaes P, Maia M, Fogaroli R, Gides D, Horriot R. Pellizzon AC, et al. Int J Med Sci. 2008 Jun 4;5(3):113-20. doi: 10.7150/ijms.5.113. Int J Med Sci. 2008. PMID: 18566673 Free PMC article.
101 results